Found 12 matching trials
A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer. PHASE2 The objective of this study is to assess the safety, efficacy, pharmacokine...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors PHASE1 The objective of this study is to assess the safety, efficacy, pharmacokine...
Show More Location
Shanghai Oriental Hospital
Learn More & Join Trial
A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer PHASE1 The objective of this study is to assess the safety, efficacy, and pharmaco...
Show More Status
Active Not Recruiting
Location
University of California Irvine Chao Family Comprehensive Cancer Center
Learn More & Join Trial
A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients PHASE2 The objective of this study is to assess the safety, efficacy, pharmacokine...
Show More Location
Fifth Medical Center of PLA General Hospital
Learn More & Join Trial
A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer PHASE2 The objective of this study is to assess the safety, efficacy, pharmacokine...
Show More Location
Anhui provincial Cancer Hospital
Learn More & Join Trial
A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer PHASE2 The objective of this study is to assess the safety, efficacy, pharmacokine...
Show More Location
The first affiliated hospital of bengbu medical college
Learn More & Join Trial
A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC) PHASE2 The objective of this study is to assess the safety, efficacy, pharmacokine...
Show More Location
Fifth Medical Center of PLA General Hospital
Learn More & Join Trial
A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer PHASE2 The primary objective of Phase II is to evaluate the safety, efficacy, phar...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer PHASE3 The primary objective of this study is to compare the overall survival (OS)...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary PHASE2 This study is a single-arm, open-label, multicenter Phase II clinical trial...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial